Assessment of Guided bone regeneration procedure with OssGuide® on dehiscence type bony defect; Unicenter Randomized Controlled Single-blinded Clinical Research

Bioland0 个研究点目标入组 30 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1. Healthy men and women over 20 years of age
•2. Patients who are needed of one or more implants restoration in the maxillary or mandible
•3. Patients who can respond in good faith on a regular recall until termination of clinical trial
•4. Patients who fully understand the details of the trial and obtain a written consent
•5. More than at least 3mm of the vertical height of bone defect after implant placement, when it is possible to ensure the primary stability

•1. Patients with uncontrolled diabetes
•2. Patients with uncontrolled hypertension
•3. Heavy smoker (= 20 cigarettes/day)
•4. Patients who are taking medication or hormones that affect bone or soft tissue metabolism
•5. Patients with history of radiation therapy or chemotherapy due to malignant neoplasm
•6. Pregnant or lactating women, or women who are taking contraceptives
•7. Patients who have or are suspected of having mental diseases
•8. Participation in another clinical trial
•9. Patients with oral cavity or severe soft tissue diseases, or who are exist untreated infectious agent such as periodontitis
•10. Patients with allergic or hypersensitivity reactions to implant, bone graft material and barrier membrane
•11. Immediate implant placemet after tooth extraction

发起方

Bioland